Category: Thoratec Corp.Syndicate content

ReliantHeart goes head-to-head with Thoratec to aim for U.S. LVAD market

April 7, 2014 by Arezu Sarvestani

ReliantHeart touts study data finding that its HeartAssist5 left ventricular assist device poses a lower risk of blood clots and damage compared with Thoratec's HeartMate II.

ReliantHeart aims for U.S. LVAD market, goes head-to-head with Thoratec

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Thoratec recall gets FDA's highest-risk label following injuries, deaths | MassDevice.com On Call

April 3, 2014 by Arezu Sarvestani

FDA regulators put their highest-risk Class I label on a recall of Thoratec's HeartMate II implantable heart pump after 5 patients injuries and 4 deaths were reportedly associated with a defect in controlling the implants.

MassDevice.com On Call

MASSDEVICE ON CALL — The FDA issued it's highest-risk Class I warning after Thoratec (NSDQ:THOR) recalled its HeartMate II implantable heart pumps over a controller issue that the FDA said was associated 4 patient deaths and 5 serious injuries.

Thoratec updates HeartMate II controller warning

March 18, 2014 by Brad Perriello

Thoratec updates its warning about the risk of switching controllers for its HeartMate II implantable heart pump.

Thoratec updates on HeartMate II controller warning

Thoratec (NSDQ:THOR) issued an update about a problem with its HeartMate II left ventricular assist device involved in 8 serious injuries or deaths.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Deaths prompt Thoratec warning on HeartMate II controller switch risk

March 5, 2014 by Brad Perriello

Thoratec warns patients with its HeartMate II heart pump about the risk of switching controllers after receiving reports of 4 deaths.

Deaths prompt Thoratec warning on HeartMate II controller switch risk

Thoratec (NSDQ:THOR) said it sent out a warning about its HeartMate II left ventricular assist device after receiving reports of 4 deaths associated with switching out the heart pump's controller.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Listen to Thoratec's Q4 2013 earnings call

February 5, 2014 by MassDevice

Company officials at Thoratec discuss the company's Q4 2013 earnings call. The company reported profits of $13.1 million, or 23¢ per diluted share, on sales of $128.2 million during the 3 months ended December 28, swinging to the black on a minor dip in sales.

Thoratec caps off 2013 and predicts healthy growth in the year to come

February 5, 2014 by Arezu Sarvestani

Thoratec gains after posting a swing to the black for its 4th quarter, driven primarily by freedom from impairment charges, and projects strong growth in 2014.

Thoratec posts another stellar quarter to top off 2013

California medical device maker Thoratec (NSDQ:THOR) posted another strong quarter to cap off a year of growth in sales and fewer hits to revenues.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp